Definitive chemoradiotherapy in Stage III nonsmall cell lung cancer: Turkey experience

Yilmaz, Ufuk; Yilmaz, Ulku; Yasar, Zehra; Kirakli, Esra; Ulger, Sukran; Ozdogan, Yasemin; DEMİRCİ, NİLGÜN; Erol, Serhat; Ozdogan, Ilker; Sahin, Burcu; KÖKSAL, DENİZ; Akcay, Cimen

doi:10.4103/0973-1482.163682

Definitive chemoradiotherapy in Stage III nonsmall cell lung cancer: Turkey experience

Yilmaz U., Yilmaz U., Yasar Z., Kirakli E. K., Ulger S., Ozdogan Y., ...More

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.12, no.1, pp.334-339, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 12 Issue: 1
Publication Date: 2016
Doi Number: 10.4103/0973-1482.163682
Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.334-339
Hacettepe University Affiliated: Yes

Abstract

Aim: Concurrent chemoradiotherapy (CRT) is the standard therapy for patients with unresectable Stage III nonsmall cell lung cancer (NSCLC). The aim of this study was to assess the efficacy and safety of concurrent CRT in unresectable Stage III NSCLC in Turkey.